Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommy Rampling

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Open Forum Infectious Diseases|August 8, 2024
A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With MpoxClare E Warrell, Zain Chaudhry, Marianne Shawe-Taylor, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 8, 2024
Histopathological findings from the investigation of paediatric acute hepatitis of unknown aetiology, United Kingdom 2022Helen Callaby, Emma McGuire, Sanjay Rajwal, et al.
Public Health|April 16, 2026
Operationalisation and findings of a First Few X (FFX) investigation of early mpox clade Ib cases and their close contacts in the United KingdomAnita A Shah, Carmellie Inzoungou-Massanga, Motolani Awokoya, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2025
Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023Helen Callaby, Kate R Beard, Dominic Wakerley, et al.
Clinical Medicine (London, England)|July 19, 2020
Experience of a novel community testing programme for COVID-19 in London: Lessons learntGabriel Wallis, Francesca Siracusa, Michael Blank, et al.
Clinical Drug Investigation|January 16, 2026
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-studyAndrew Ustianowski, Myron J Levin, Stephane De Wit, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 14, 2025
Case series of the first five human infections with monkeypox virus clade Ib and report on the public health response, United Kingdom, October to November 2024Muhammad Ibaad Alvi, Merav Kliner, William Welfare, et al.
Nature Communications|September 23, 2023
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individualsAshley D Otter, Scott Jones, Bethany Hicks, et al.
Plos One|December 13, 2018
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and childrenAlfred B Tiono, Issa Nébié, Nicholas Anagnostou, et al.
The Lancet. Infectious Diseases|May 27, 2022
Clinical features and management of human monkeypox: a retrospective observational study in the UKHugh Adler, Susan Gould, Paul Hine, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Open Forum Infectious Diseases|August 8, 2024
A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With MpoxClare E Warrell, Zain Chaudhry, Marianne Shawe-Taylor, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 8, 2024
Histopathological findings from the investigation of paediatric acute hepatitis of unknown aetiology, United Kingdom 2022Helen Callaby, Emma McGuire, Sanjay Rajwal, et al.
Public Health|April 16, 2026
Operationalisation and findings of a First Few X (FFX) investigation of early mpox clade Ib cases and their close contacts in the United KingdomAnita A Shah, Carmellie Inzoungou-Massanga, Motolani Awokoya, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2025
Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023Helen Callaby, Kate R Beard, Dominic Wakerley, et al.
Clinical Medicine (London, England)|July 19, 2020
Experience of a novel community testing programme for COVID-19 in London: Lessons learntGabriel Wallis, Francesca Siracusa, Michael Blank, et al.
Clinical Drug Investigation|January 16, 2026
Safety and Pharmacokinetics of Repeat Dosing of Long-Acting SARS-CoV-2 Antibodies Tixagevimab/Cilgavimab (AZD7442): Results from the PROVENT Sub-studyAndrew Ustianowski, Myron J Levin, Stephane De Wit, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 14, 2025
Case series of the first five human infections with monkeypox virus clade Ib and report on the public health response, United Kingdom, October to November 2024Muhammad Ibaad Alvi, Merav Kliner, William Welfare, et al.
Nature Communications|September 23, 2023
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individualsAshley D Otter, Scott Jones, Bethany Hicks, et al.
Plos One|December 13, 2018
First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and childrenAlfred B Tiono, Issa Nébié, Nicholas Anagnostou, et al.
The Lancet. Infectious Diseases|May 27, 2022
Clinical features and management of human monkeypox: a retrospective observational study in the UKHugh Adler, Susan Gould, Paul Hine, et al.
Pageof 5